T2 weighted MRI and Histopathology as Markers for Response to Somatostatin Analogues in Acromegaly
Metadata
Show metadataAppears in the following Collection
- Institutt for klinisk medisin [10636]
Abstract
No abstract.List of papers
Paper 1 Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly Fougner SL, Casar-Borota O, Heck A, Berg JP, Bollerslev J. Clinical Endocrinology (Oxf); 2012; 76(1):96-102 The paper is not available in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1111/j.1365-2265.2011.04163.x |
Paper 2 Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly Heck A, Ringstad G, Fougner SL, Casar-Borota O, Nome T, Ramm-Pettersen J, Bollerslev J. Clinical Endocrinology (Oxf); 2012; 77(1):72-78. The paper is not available in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1111/j.1365-2265.2011.04286.x |
Paper 3 Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide Casar-Borota O, Heck A, Schulz S, Nesland JM, Ramm-Pettersen J, Lekva T, Alafuzoff I, Bollerslev J. The Journal of Clinical Endocrinology and Metabolism. 2013; 98(11):E1730-9. The paper is not available in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1210/jc.2013-2145 |
Paper 4 Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly Heck A, Emblem KE, Casar-Borota O, Bollerslev J, Ringstad G Endocrine, 2015; 52(4):333-343. The paper is not available in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1007/s12020-015-0766-8 |
Paper 5 MRI T2 characteristics in somatotroph adenomas following somatostatin analog treatment in acromegaly Heck A, Emblem KE, Casar-Borota O, Ringstad G, Bollerslev J Endocrine, 2015, available online 28 Nov 2015. The paper is not available in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1007/s12020-015-0816-2 |